SSRI plus tramadol: serotonin syndrome and seizure risk

Why this combination is a problem

Tramadol's pharmacology is unusual for an opioid. It has three simultaneous mechanisms:

1. Weak mu-opioid receptor agonist (both parent drug and its active metabolite O-desmethyltramadol)
2. Serotonin reuptake inhibitor (weak SSRI)
3. Norepinephrine reuptake inhibitor (weak SNRI)

The serotonergic activity is what causes the problem when combined with SSRIs or SNRIs. Two serotonergic mechanisms stacked (SSRI + tramadol) raise synaptic serotonin further than either alone.

Tramadol also lowers seizure threshold, especially at higher doses. SSRIs modestly lower seizure threshold as well. The combination amplifies the effect. Case reports of tramadol-plus-SSRI seizures are well documented.

Actual incidence

Real-world incidence of serotonin syndrome from the combination is low. Large observational databases suggest less than 1 percent of patients on both drugs develop clinically significant syndrome. Mild symptoms (jitteriness, tremor) are more common but often unrecognized.

Seizure incidence in patients on tramadol is around 0.5 to 1 percent at usual doses, higher at doses above 400 mg per day. Adding an SSRI likely doubles the risk though precise numbers vary across studies.

The most-cited concerning case series come from tramadol overdose settings, where serotonin toxicity is much more prominent.

When the combination happens in real practice

• Patient on sertraline gets tramadol after dental extraction
• Patient on venlafaxine for chronic pain and depression starts tramadol for acute back pain
• Patient on fluoxetine gets prescribed tramadol for chronic musculoskeletal pain when the prescriber does not review the antidepressant list
• Patient in recovery from opioid use disorder on an SSRI for depression is prescribed tramadol (perceived as "safer" than other opioids)

Better alternatives

For acute pain in a patient on an SSRI/SNRI, options in rough order of preference:

1. Non-opioid non-serotonergic first: acetaminophen, NSAIDs (if no bleeding risk, no lithium, no significant kidney disease), regional anesthesia, ice, mobilization.
2. Suzetrigine (Journavx): FDA-approved January 2025 non-opioid Nav1.8 sodium channel blocker for moderate to severe acute pain. No serotonergic activity, no opioid receptor binding, no interaction with SSRIs. See our Journavx state of practice.
3. Non-serotonergic opioids if opioid is truly needed: morphine, oxycodone, hydrocodone, hydromorphone. Fentanyl is weakly serotonergic but the risk in acute short-term use is low. Meperidine should be avoided entirely.

For chronic pain in a patient on an SSRI/SNRI, options:

1. Non-opioid multimodal: acetaminophen, NSAIDs, gabapentin or pregabalin for neuropathic pain, topical agents (lidocaine, capsaicin), physical therapy.
2. SNRIs for chronic pain (duloxetine, milnacipran, venlafaxine) work through the same serotonergic and noradrenergic mechanism that helps mood, so a single drug covers both indications.
3. TCAs at low doses (amitriptyline 10 to 50 mg at bedtime, nortriptyline) for neuropathic pain. Adding to an SSRI raises anticholinergic burden.

When tramadol combined with SSRI is still acceptable

• Short courses (3 to 5 days) at low doses (50 to 100 mg per dose, maximum 200 to 400 mg per day) for acute pain where alternatives are less appropriate
• Patients already stable on both drugs long-term without symptoms
• Situations where the pain-relief benefit clearly outweighs the small marginal serotonin syndrome risk

Monitoring

If the combination is used, be explicit with the patient about:

• Signs of serotonin syndrome (agitation, tremor, sweating, muscle jerks, fever, confusion)
• When to seek care immediately
• Not to escalate tramadol dose beyond what was prescribed

Common questions

How likely is serotonin syndrome from a short course of tramadol on an SSRI? Low. Most patients tolerate short courses at usual doses. Clinically significant syndrome from the combination is probably under 1 percent at usual doses. Severe cases have been reported but are uncommon.

Should I stop my SSRI to take tramadol after surgery? Almost never. Stopping an SSRI carries its own risks (discontinuation syndrome, depression recurrence, especially over a stressful post-surgical period). The better approach is to use non-tramadol pain management, or accept the small serotonin syndrome risk with informed monitoring.

Is tramadol safer than other opioids for a patient on an SSRI? No. This is a common misconception. Tramadol carries more interaction risk with SSRIs than morphine, oxycodone, or hydrocodone because of its serotonergic activity. Non-tramadol opioids are usually safer for SSRI patients when an opioid is needed.

What about fentanyl in a patient on an SSRI? Fentanyl has weak serotonergic activity and can theoretically cause serotonin syndrome. In practice, fentanyl is used very commonly in patients on SSRIs during anesthesia and post-op with rare clinically significant syndrome. The risk is real but low, and short-term use is generally accepted.

Can I take Tylenol PM with my SSRI? Tylenol PM contains acetaminophen plus diphenhydramine. The acetaminophen is fine with SSRIs. The diphenhydramine adds anticholinergic burden (see our anticholinergic burden page) and causes sedation. Occasional use in young healthy adults is low risk. Regular use, especially in older adults, is not recommended.

Which opioids should NEVER be combined with an MAOI? Meperidine (Demerol) and tramadol have historical high-mortality combinations with MAOIs. Fentanyl and morphine have been used with MAOIs in anesthesia settings with careful monitoring. See our MAOI plus tyramine and drug interactions page.

Sources

• Beakley BD, Kaye AM, Kaye AD. Tramadol, pharmacology, side effects, and serotonin syndrome: a review. Pain Physician. 2015;18(4):395-400.
• Nelson EM, Philbrick AM. Avoiding serotonin syndrome: the nature of the interaction between tramadol and selective serotonin reuptake inhibitors. Ann Pharmacother. 2012;46(12):1712-1716.
• FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines. August 31, 2016.
• Talarico JF, Metro DG. Presentation of dental patients on tramadol and simultaneous SSRI/SNRI therapy. Anesth Prog. 2018;65(1):19-23.
• Sansone RA, Sansone LA. Tramadol: seizures, serotonin syndrome, and coadministered antidepressants. Psychiatry (Edgmont). 2009;6(4):17-21.